RTTNews | Sep 28, 2020 10:45AM EDT

10:45 Monday, September 28, 2020 (RTTNews.com) - Shares of Celldex Therapeutics, Inc. (CLDX) are rising more than 20 percent or $2.59 in Monday's morning trade at $15.39, after touching a new 52-week high of $15.65 earlier despite no specific news that could influence the stock.

U.S. stocks are rising on Monday, extending gains from the previous session, as investors shrugged off concerns about a surge in coronavirus cases and uncertainty about the U.S. presidential election.

Celldex is a biopharmaceutical company that focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics.

Celldex Therapeutics has traded in a range of $1.50 to $15.65 in the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3131888/stock-alert-celldex-therapeutics-climbs-to-new-52-week-high.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved